NeuroPace (NPCE) Net Income Growth (1y) (2021 - 2026)
NeuroPace (NPCE) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | -0.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26% |
| Dec 31, 2025 | 47.15% |
| Sep 30, 2025 | 36.91% |
| Jun 30, 2025 | -6.96% |
| Mar 31, 2025 | 27.51% |
| Dec 31, 2024 | 20.12% |
| Sep 30, 2024 | 23.07% |
| Jun 30, 2024 | 17.43% |
| Mar 31, 2024 | 6.09% |
| Dec 31, 2023 | 41.23% |
| Sep 30, 2023 | 36.89% |
| Jun 30, 2023 | 26.65% |
| Mar 31, 2023 | 16.58% |
| Dec 31, 2022 | -2.89% |
| Sep 30, 2022 | -47.26% |
| Jun 30, 2022 | -97.63% |
| Mar 31, 2022 | -101.12% |
| Dec 31, 2021 | -119.80% |
| Sep 30, 2021 | -100.43% |
| Jun 30, 2021 | 12.14% |